An interventional study of Internal Family Systems (IFS) in PTSD and Depression, sponsored by Justice Resource Institute. Completed. Open to participants aged 18 Years to 56 Years. Per ClinicalTrials.gov, last updated 2021-12-14.
Sponsored by Justice Resource Institute · Not applicable, Interventional, and Treatment
Study examining the effectiveness of 16 weeks of Internal Family Systems (IFS) therapy for adults with posttraumatic stress disorder (PTSD).
Evaluation study of IFS therapy among trauma-impacted adults in order to explore the applicability of IFS with this population, ensure fidelity of treatment administration, and examine initial efficacy. Evaluate the utility of IFS in reducing symptoms of PTSD, dissociation and depression and increasing self-regulatory capacity, self-awareness and self-compassion. 15 subjects between the ages of 18 and 56 who are receiving 16, 90-minute sessions of IFS therapy by certified IFS practitioners in the community will be recruited for this evaluation study. Blind evaluators will assess treatment effects at pre-treatment, mid-treatment, post-treatment and at one-month follow-up, measuring change in symptoms of PTSD, dissociation and depression, as well as self-regulation, self-compassion, and interoceptive awareness.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 17 is below the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →Justice Resource Institute is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Internal Family Systems (IFS)
Behavioral: Internal Family Systems (IFS)
Weekly individual psychotherapy
Change in Clinician Administered PTSD Scale (CAPS) total score from pre- to post-treatment and 1-month follow up
A 30-item validated instrument that contains frequency and intensity scales for PTSD symptoms . Subscales assess intrusion, avoidance, arousal and associated affective features.
Time frame: Change from baseline in PTSD symptom severity at up to 16 weeks of treatment and 1-month follow up.
Change in PTSD symptoms per the Davidson Trauma Scale (DTS) across four study time points
Self-report of PTSD symptoms per DSM IV criteria.
Time frame: Change from baseline in PTSD symptom severity at up to 8 weeks of treatment, 16 weeks of treatment and 1-month follow up.
Change in symptoms of depression per the Beck Depression Inventory (BDI) across 4 study time points
21-item, self-report measure of symptoms of depression.
Time frame: Change from baseline in PTSD symptom severity at up to 8 weeks of treatment, 16 weeks of treatment and 1-month follow up.
Change in interoceptive awareness per the Multidimensional Assessment of Interoceptive Awareness (MAIA) across 4 study time points
32-item, self-report measure that assesses interoceptive body awareness across eight distinct but related dimensions: noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trusting.
Time frame: Change from baseline in PTSD symptom severity at up to 8 weeks of treatment, 16 weeks of treatment and 1-month follow up.
Change in symptoms of dissociation per the Structured Interview for Disorders of Extreme Stress, Self-Report Version (SIDES-SR) over 4 study time points
45 item, validated self-report measure assessing six domains of impairment secondary to complex trauma exposure. Assessed areas include alterations in (a) regulation of affect and impulses, (b) attention and consciousness, (c) self-perception, (d) relation with others, (e) somatization, and (f) systems of meaning.
Time frame: Change from baseline in PTSD symptom severity at up to 8 weeks of treatment, 16 weeks of treatment and 1-month follow up.
Change in self-compassion per the Self Compassion Scale over four study time points
26 item self report outcome measure assessing components of compassion towards the self including self-kindness, common humanity, and mindfulness.
Time frame: Change from baseline in PTSD symptom severity at up to 8 weeks of treatment, 16 weeks of treatment and 1-month follow up.
No study locations are listed for this record.
Plan to share: No — IPD will not be shared with other researchers.
This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Justice Resource Institute